Liver Biopsy

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and FibrosisNCT03900429MDGLPhase 3Active not recruiting2028-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.